ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB Press release LEIDEN, the Netherlands, April 30, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 30, 2018
ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. September 07, 2023
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. December 22, 2022
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. May 02, 2025
ProQR Therapeutics Provides Update on Ophthalmic Assets Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 27, 2023
ProQR Announces Upcoming Investor Conferences in April and May Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. April 20, 2023
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. May 04, 2026
ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. May 01, 2025
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. March 25, 2026
ProQR Announces Planned Changes to Board Composition Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 09, 2026